Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN TECHNOLOGIES

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 31

FDA approve RIVASTIGMINE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 29

FDA approve NIMODIPINE

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 31

FDA approve PROCHLORPERAZINE MALEATE

Comment Full text

INNOGENIX

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 31

FDA approve HALOPERIDOL

Comment Full text

KYOWA KIRIN

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 23

FDA approve MOGAMULIZUMAB-KPKC

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 29

FDA approve ERTUGLIFLOZIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 22

FDA approve DARUNAVIR

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 21

FDA approve ELTROMBOPAG OLAMINE

Comment Full text

JANSSEN PHARMS

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 29

FDA approve HALOPERIDOL DECANOATE

Comment Full text

COSETTE

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 27

FDA approve PROCHLORPERAZINE

Comment Full text
  • Previous
  • 90
  • 91
  • 92
  • 93
  • 94
  • Next

Search

News categories

  • Technical Exchange News(9375)
  • Event(407)
  • SEC News(153222)
  • FDA Approval(8741)
  • Company Report(721)
  • Business News(104499)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin